Stay updated on Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe study record no longer lists the 2016 NIH grant/contract identifier, and the site revision advances from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Morpheus-Pancreatic Cancer study record is displayed with details on its treatment combinations, eligibility, locations, and measured outcomes. It is marked completed and no longer recruiting, with results and a study protocol document available.SummaryDifference98%

- Check22 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA sitewide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content.SummaryDifference1%

- Check36 days agoChange DetectedThe site revision identifier changes from v3.7.1 to v3.7.2. The page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page.